These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32119084)

  • 41. Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.
    Von Kreudenstein TS; Escobar-Carbrera E; Lario PI; D'Angelo I; Brault K; Kelly J; Durocher Y; Baardsnes J; Woods RJ; Xie MH; Girod PA; Suits MD; Boulanger MJ; Poon DK; Ng GY; Dixit SB
    MAbs; 2013; 5(5):646-54. PubMed ID: 23924797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgNAR characterization and gene loci identification in whitespotted bamboo shark (Chiloscyllium plagiosum) genome.
    Jia L; Wang Y; Shen Y; Zhong B; Luo Z; Yang J; Chen G; Jiang X; Chen J; Lyu Z
    Fish Shellfish Immunol; 2023 Feb; 133():108535. PubMed ID: 36649810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF
    Camacho-Villegas TA; Mata-González MT; García-Ubbelohd W; Núñez-García L; Elosua C; Paniagua-Solis JF; Licea-Navarro AF
    Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
    Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H
    J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
    Skegro D; Stutz C; Ollier R; Svensson E; Wassmann P; Bourquin F; Monney T; Gn S; Blein S
    J Biol Chem; 2017 Jun; 292(23):9745-9759. PubMed ID: 28450393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
    Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
    Front Immunol; 2020; 11():560244. PubMed ID: 33324393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.
    Feige MJ; Gräwert MA; Marcinowski M; Hennig J; Behnke J; Ausländer D; Herold EM; Peschek J; Castro CD; Flajnik M; Hendershot LM; Sattler M; Groll M; Buchner J
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8155-60. PubMed ID: 24830426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.
    Manoutcharian K; Gevorkian G
    Fish Shellfish Immunol; 2023 Jul; 138():108808. PubMed ID: 37169114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of Immune and Synthetic VNAR Libraries as Sources of High-Affinity Binders.
    Gasperin-Bulbarela J; Cabanillas-Bernal O; Dueñas S; Licea-Navarro AF
    Methods Mol Biol; 2022; 2446():71-93. PubMed ID: 35157269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bamboo Shark as a Small Animal Model for Single Domain Antibody Production.
    Wei L; Wang M; Xiang H; Jiang Y; Gong J; Su D; Al Azad MAR; Dong H; Feng L; Wu J; Chan LL; Yang N; Shi J
    Front Bioeng Biotechnol; 2021; 9():792111. PubMed ID: 34957081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
    Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
    Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?
    Jiang X; Sun L; Hu C; Zheng F; Lyu Z; Shao J
    Mar Drugs; 2023 Sep; 21(9):. PubMed ID: 37755109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of shark VNARs targeting the
    Gao Y; Wang R; Liu L; Feng S; Xi X; Yu W; Gu Y; Wang Y
    Artif Cells Nanomed Biotechnol; 2023 Sep; 51(1):509-519. PubMed ID: 37695066
    [No Abstract]   [Full Text] [Related]  

  • 54. [Advances in the study of natural small molecular antibody].
    Zhu L; Zhang DP
    Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.
    Kovaleva M; Ferguson L; Steven J; Porter A; Barelle C
    Expert Opin Biol Ther; 2014 Oct; 14(10):1527-39. PubMed ID: 25090369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequence structure character of IgNAR Sec in whitespotted bamboo shark (Chiloscyllium plagiosum).
    Zhang W; Qin L; Cai X; Juma SN; Xu R; Wei L; Wu Y; Cui X; Chen G; Liu L; Lv Z; Jiang X
    Fish Shellfish Immunol; 2020 Jul; 102():140-144. PubMed ID: 32311460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
    Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF
    PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of monoclonal shark-derived immunoglobulin new antigen receptor antibodies using Chinese hamster ovary cell expression system.
    Enatsu H; Okamoto N; Nomura Y; Onitsuka M; Yamano-Adachi N; Koga Y; Omasa T
    J Biosci Bioeng; 2021 Sep; 132(3):302-309. PubMed ID: 34119424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development.
    Ubah OC; Steven J; Kovaleva M; Ferguson L; Barelle C; Porter AJR; Barelle CJ
    Front Immunol; 2017; 8():1780. PubMed ID: 29312310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
    Cabanillas-Bernal O; Valdovinos-Navarro BJ; Cervantes-Luevano KE; Sanchez-Campos N; Licea-Navarro AF
    Front Immunol; 2023; 14():1257042. PubMed ID: 37753081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.